Clinical trial to investigate safety and feasibility of Roux-Y with aboral pouch reconstruction after laparoscopically assisted total gastrectomy

Clinical trial to investigate safety and feasibility of Roux-Y with aboral pouch reconstruction after laparoscopically assisted total gastrectomy - Safety and feasibility of Roux-Y with aboral pouch reconstruction after laparoscopically assisted total gastrectomy

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005120

Enrollment

Registered

2011-06-01

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Patients participated in this study undergo laparoscopically assisted total gastrectomy with Roux-Y with aboral pouch reconstruction.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) A gastric cancer patient diagnosed as clinical stage 1A-2B (Japanese Classification of Gastric Carcinoma The 14th Edition). 2) Planned to receive laparoscopically assisted total gastrectomy. 3) ECOG Performance Status Scale: 0-1. 4) Greater than or equal to 20 years of age and less than or equal to 85 years of age. 5) BMI (Body Mass Index): less than or equal to 25 Kg/m2 6) Meet the above-mentioned conditions and able to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1) Neo-adjuvant chemotherapy within four weeks prior to the operation. 2) Coexistence/past history of any inflammatory bowel disease; ulcerative colitis or Crohn's disease. 3) Emergency operation. 4) Double cancer. 5) Resection of adjacent organs except gallbladder 6) Use of anticoagulation and/or antiplatelet agents 7) Dysfunction of major organs. 8) During pregnancy and lactation 9) Any other condition that, in the investigator's opinion, places the subject at undue risk by participating in the study.

Design outcomes

Primary

Measure	Time frame
Postoperative hospital stay	—

Countries

Japan

Contacts

Public ContactNaoki Tanaka

Tohoku University Hospital Division of Gastrointestinal Surgery

n-tanaka@surg1.med.tohoku.ac.jp022-717-7205

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026